2024 International Congress

September 27-October 1, 2024. Philadelphia, PA.

View by Title View Sessions

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Real-world Experiences of Image-guided Programming in Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s disease

J S. Lee, J. Ha, J W. Cho, J. Lee, J. Youn (Daegu, Republic of Korea)
Real-World Multicenter Analysis of Levodopa Equivalent Daily Dosage Algorithms- Capturing Geographical and Demographic Disparities in Parkinson’s Disease Therapy Spanning Six Countries and Two Continents

P. Kukkle, L. Kalia, A. Habib, P. Jagota, R. Ojha, R. Kandadai, S. Desai, M. Caldera, D. Sirisena, D. Garg, T. Mestre, R. Neupane, S. Maytharakcheep, K. Sanyawut, R. Borgohain (Bangalore, India)
Real-world Programming and Sensing from Adaptive Deep Brain Stimulation for Parkinson’s Disease in Japan

G. Oyama, K. Kimura, H. Kishima, N. Murase, Y. Tsuboi, T. Tsuboi, T. Takezaki, Y. Higuchi, T. Hashimoto, Y. Shimo, T. Brionne, I. Buffin, K. Hidaka, F. Coletti, R. Amit, N. Morelli, H. Mure, H. Oshima (Tokyo, Japan)
Real-World Retrospective Safety Analysis in Patients Treated With OnabotulinumtoxinA for Multiple Therapeutic Indications Over Repeat Treatment Periods

G. Forde, A. Patel, K. Martinez, A. Mayadev, B. Brucker, T. Brown, Z. Ayyoub, R. Singh, M. Nelson, A. Ukah, I. Yushmanova, S. Battucci, K. Becker Ifantides, C. Rhyne (New Hyde Park, USA)
Real-world use of biomarkers for Parkinsonism: Should I do this (pSyn) or DaT?

A. Martinez Nunez, N. Walker-Pizarro, A. Wagle Shukla, A. Ramirez-Zamora, N. Mcfarland (Gainesvile, USA)
Recrudescence of a Compensated Hemidystonia-hemiatrophy Syndrome After COVID-19 Infection

A. Kundrick, H. Fernandez (Cleveland, USA)
Recruitment of Ethnoracially Diverse Participants for Disease-Modifying Drug Trials in Parkinson’s Disease: Are We Doing It Right? A Systematic Review and Meta-Analysis.

F. Reis Rodrigues, E. Pasqualotto, G. Ribeiro, J. M. Couto, E. Bayram, M. Ushe, D. Di Luca (Vicosa, Brazil)
Reduced intestinal inflammation and increased levels of short-chain fatty acids thanks to an active lifestyle in Parkinson’s disease.

NES. Chtioui, CHR. Duval, DAV. St-Pierre (Montreal, Canada)
Reduced parietal and sensorimotor cortex recruitment during complex gait in Parkinson’s disease patients with freezing of gait

N. D'Cruz, M. Goris, C. Mccrum, A. Nieuwboer, M. Gilat (Leuven, Belgium)
Reduced plasma levels of various cell signaling molecules in patients with Parkinson’s Disease

S. Zadegan, A. Teixeira, E. Furr Stimming, N. Pessoa Rocha (Housotn, USA)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z